Αποτελέσματα Αναζήτησης
ORTHO EVRA ® is a combination transdermal contraceptive patch with a contact surface area of 20 cm. 2. It contains 6.00 mg norelgestromin (NGMN) and 0.75 mg ethinyl estradiol (EE). Systemic...
20 Μαΐ 2024 · You can ask your pharmacist or healthcare provider for information about ORTHO EVRA that is written for health professionals. For more information, go to www.orthoevra.com or call 1-800-JANSSEN (1-800-526-7736). What are the ingredients in ORTHO EVRA? Active ingredient: norelgestromin and ethinyl estradiol
Generic Allegra-D Approved. A combination of fexofenadine HCl and pseudoephedrine HCl in an extended-re-lease tablet (60 mg/120 mg) is indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and chil-dren 12 years and older.
EVRA® 203 micrograms/24 hours + 33.9 micrograms/24 hours transdermal patch PRESCRIBING INFORMATION . ACTIVE INGREDIENT(S): Norelgestromin (NGMN) and ethinyl estradiol (EE). Please refer to Summary of Product Characteristics (SmPC) before prescribing. INDICATION(S): Female contraception, intended for women of fertile age. Safety/efficacy
1. NAME OF THE MEDICINAL PRODUCT. EVRA 203 micrograms/24 hours + 33.9 micrograms/24 hours transdermal patch. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION. Each 20 cm2 transdermal patch contains 6 mg norelgestromin (NGMN) and 600 micrograms ethinyl estradiol (EE).
Evra is a transdermal patch (a patch that delivers a medicine across the skin). For the first three weeks of the menstrual cycle a new patch should be applied every week, followed by a fourth week, which is patch-free.
ORTHO EVRATM is a combination transdermal contraceptive patch with a contact surface area of 20 cm2. It contains 6.00 mg norelgestromin and 0.75 mg ethinyl estradiol (EE), and releases 150 micrograms of norelgestromin and 20 micrograms of EE to the bloodstream per 24 hours.
